Lantheus Holdings LNTH
NASDAQ LNTH
$99.97 -0.27 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lantheus Holdings (LNTH) Cash from Investing Activities (2014 - 2026)

Lantheus Holdings (LNTH) posted quarterly Cash from Investing Activities of $26.0 million for Q1 2026, up 140.78% year-over-year from $10.8 million in Q1 2025, and up 325.77% quarter-over-quarter from -$11.5 million in Q4 2025.

Lantheus Holdings (LNTH) Cash from Investing Activities (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has reported Cash from Investing Activities for 13 consecutive years, with $26.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 140.78% year-over-year to $26.0 million; the TTM figure through Mar 2026 stood at -$537.5 million (down 193.37% YoY), while the FY2025 annual figure was -$627.2 million, down 177.49% from the prior year.
  • Cash from Investing Activities improved to $26.0 million in Q1 2026 per LNTH's latest filing, from -$11.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $83.2 million in Q3 2023 and bottomed at -$319.5 million in Q3 2025.
  • Historically, Cash from Investing Activities has averaged -$64.6 million across 5 years, with a median of -$20.7 million in 2023.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 5725.79% — and 2023, when it jumped 1466.47%.
  • Lantheus Holdings' Cash from Investing Activities stood at -$264.7 million in 2022, then jumped by 95.44% to -$12.1 million in 2023, then jumped by 45.3% to -$6.6 million in 2024, then plunged by 74.34% to -$11.5 million in 2025, then surged by 325.77% to $26.0 million in 2026.
  • Business Quant data shows LNTH's Cash from Investing Activities at $26.0 million in Q1 2026, -$11.5 million in Q4 2025, and -$319.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -491.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Lantheus Holdings 6.52 Bn 5.93 Bn 241.86 Mn -2.02 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.02 Mn
Jun 30, 2026 -2.02 Mn
Mar 31, 2026 25.99 Mn
Mar 31, 2026 25.99 Mn
Dec 31, 2025 -11.51 Mn
Dec 31, 2025 -11.51 Mn
Sep 30, 2025 -319.47 Mn
Sep 30, 2025 -319.47 Mn
Jun 30, 2025 -232.47 Mn
Jun 30, 2025 -232.47 Mn
Mar 31, 2025 -63.72 Mn
Mar 31, 2025 -63.72 Mn
Dec 31, 2024 -6.60 Mn
Dec 31, 2024 -6.60 Mn
Sep 30, 2024 -67.80 Mn
Sep 30, 2024 -67.80 Mn
Jun 30, 2024 -45.09 Mn
Jun 30, 2024 -45.09 Mn
Mar 31, 2024 -106.53 Mn
Mar 31, 2024 -106.53 Mn